# The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy

> **NCT03040856** · NA · WITHDRAWN · sponsor: **Sheba Medical Center**

## Conditions studied

- Omega 3 Supplements During Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha Linolenic Acid
- **DIETARY_SUPPLEMENT:** Omega 3 enriched diet ( DHA+EPA)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03040856
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Problems executing the study
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040856, "The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03040856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*